Competitive Intelligence Senior Manager, Obesity
Amgen
Summary
In this vital role, you will lead competitive intelligence activities as a key member of the Obesity Competitive Intelligence team within Obesity Intelligence & Analytics. You will serve as a key partner to Obesity leadership and cross-functional teams, translating rapidly evolving competitive developments into actionable insights that inform asset and portfolio strategy.
Job description
Key Responsibilities
- Be a strategic thought partner to Obesity leadership and cross-functional teams, bringing a competitive perspective to key business decisions
- Synthesize complex intelligence into strategic insights and clear implications for Amgen's portfolio and business strategy
- Work in a highly cross functional manner and manage changing priorities across key stakeholders
- Develop productive relationships with Global and Regional teams to define business problems and develop integrated analysis plans based on standard methodologies
- Apply structured problem solving to collect, analyze and report CI, incorporating primary and secondary data sources to generate meaningful insights
- Articulate the impact of changing market dynamics and competitive developments to key stakeholders
- Organize and facilitate strategic exercises & competitive simulations to generate competitive insights and company plans
- Lead CI planning and intelligence collection at major medical congresses, working cross-functionally to translate emerging data and insights into timely implications for stakeholders
- Manage a network of primary data sources, including vendors and Amgen employees, to enable effective project delivery
- Collaborate with fellow CI leads to advance competitive intelligence capabilities and best practices
- Synthesize CI research findings while maintaining high standards for accuracy, relevance, and quality, and clearly communicate the strength of evidence to key partners
- Present strategic analysis, insights, implications, and recommendations to key stakeholders and leadership
- Abide by and strictly enforce Amgen's CI Legal and Ethical Guidelines with internal colleagues and agencies
- Some travel (15-20%) required
Basic Qualifications
- Doctorate degree and 2 years of competitive intelligence or similar experience OR
- Master's degree and 4 years of competitive intelligence or similar experience OR
- Bachelor's degree and 6 years of competitive intelligence or similar experience OR
- Associate's degree and 10 years of competitive intelligence or similar experience OR
- High school diploma / GED and 12 years of competitive intelligence or similar experience
Preferred Qualifications
- Advanced degree (PhD/MS/MBA) with a focus on life sciences and business
- Experience within life science consulting work in obesity and/or other metabolic conditions
- Familiarity with biopharma industry
- Relevant experience in obesity via prior project work, disease area knowledge
- Prior experience in strategy/management consulting in the biopharma industry, roles of increasing responsibility
- Demonstrated ability to think strategically and analyze data to support critical business decisions
- Ability to operate effectively in a fast-paced, rapidly evolving environment and deliver high-quality insights under tight timelines
- Excellent oral, written, and presentation skills—able to explain complex concepts clearly to a variety of audiences
- Evident project management skills—able to manage multiple, simultaneous projects and data sources
- Demonstrated analytical skills—understands the advantages and limits of different analytical approaches and studies
- Ability to work collaboratively in team-based environment
- Strong understanding of the latest developments and trends in the obesity space, key competitive dynamics and unmet medical needs
Requirements
- Doctorate degree and 2 years of competitive intelligence or similar experience OR Master's degree and 4 years of competitive intelligence or similar experience OR Bachelor's degree and 6 years of competitive intelligence or similar experience OR Associate's degree and 10 years of competitive intelligence or similar experience OR High school diploma / GED and 12 years of competitive intelligence or similar experience
- Advanced degree (PhD/MS/MBA) with a focus on life sciences and business
- Experience within life science consulting work in obesity and/or other metabolic conditions
- Familiarity with biopharma industry
- Relevant experience in obesity via prior project work, disease area knowledge
- Prior experience in strategy/management consulting in the biopharma industry, roles of increasing responsibility
- Demonstrated ability to think strategically and analyze data to support critical business decisions
- Ability to operate effectively in a fast-paced, rapidly evolving environment and deliver high-quality insights under tight timelines
- Excellent oral, written, and presentation skills—able to explain complex concepts clearly to a variety of audiences
- Evident project management skills—able to manage multiple, simultaneous projects and data sources
- Demonstrated analytical skills—understands the advantages and limits of different analytical approaches and studies
- Ability to work collaboratively in team-based environment
- Strong understanding of the latest developments and trends in the obesity space, key competitive dynamics and unmet medical needs
Benefits
- Retirement and Savings Plan
- Medical, Dental & Vision
- Life and Disability Insurance
- Flexible Spending Accounts
- Annual Bonus Program
- Stock-Based Long-Term Incentives
- Paid Time Off
- Career Development Opportunities
Company overview
Amgen Inc. is a leading American multinational biopharmaceutical company headquartered in Thousand Oaks, California, founded in 1980. As one of the world's largest independent biotechnology companies, Amgen specializes in discovering, developing, manufacturing, and delivering innovative human therapeutics. The company focuses on six key therapeutic areas: inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience. Amgen's portfolio includes blockbuster drugs such as Enbrel for autoimmune diseases, Prolia and XGEVA for osteoporosis, Repatha for cholesterol management, Otezla for psoriasis, and Neulasta for chemotherapy-induced neutropenia. With approximately 28,000 employees worldwide, Amgen operates as a component of both the Dow Jones Industrial Average and Nasdaq-100 indices. The company maintains a robust research and development pipeline with numerous clinical programs across various stages, leveraging cutting-edge biotechnology and human genetic data to address some of the world's most challenging diseases. Amgen's manufacturing capabilities span multiple global locations, and it distributes products through pharmaceutical wholesale distributors and direct-to-consumer channels.